chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin increased, Hypotension, Lung abscess, Metabolic function test normal, Peripheral swelling
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Positive airway pressure therapy, Productive cough, Psoriasis, Pulmonary embolism
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary infarction, Pyrexia, Respiratory failure, SARS-CoV-2 test positive, Sputum culture positive
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sputum discoloured, Staphylococcus test positive, Swelling, Treatment noncompliance, White blood cell count normal
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Pain
Clinical narrative: I tested positive for COVID 01/28/2022 with a home test. At was a mild to moderate. I didn't have to go to the hospital. I had trouble breathing, a cough, chills, fever, and body ache. I spent most of the time in bed. I had it for about 5 days. I had COVID twice. I can't remember the first time.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID 01/28/2022 with a home test. At was a mild to moderate. I didn't have to go to the hospital. I had trouble breathing, a cough, chills, fever, and body ache. I spent most of the time in bed. I had it for about 5 days. I had COVID twice. I can't remember the first time.
Age: 25.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: Patient was hospitalized . Presented to the emergency department with hypoxia. Was inpatient for 2 days.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID 19 that lead to hospitalization.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Canalith repositioning procedure, Dizziness, Vertigo, Vomiting
Clinical narrative: I was at a class where you get up and down to do the exercises. All of a sudden, the room started spinning and got really dizzy. I stopped my activity and the dizziness subsided and when I moved around, I would get dizzy again. I stopped the activities and went home. Symptoms included Light headedness and dizziness for the next couple days. Vomiting. Treated it with a maneuver with the Epley maneuver to help with the ear crystals. Took an anti-nausea medication meclizine and by the end of the week I haven't experienced any symptoms. Did have a telehealth visit with my doctor. Symptoms have resolved.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 87.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Chills, Headache
Clinical narrative: Night of vaccination, I began to get in the middle of the night, feverish. Could not get out of bed. I had a severe headache, i was shivering, and my arm was killing me. I was so nauseous, couldn't take anything for my head. I could not get out of bed. Finally around 5-6 am, i managed to get out the bed. I had cramps and stomach pain. After that, I had achiness in my knees. Today is the first day that my arm is not sore. I didnt even want to go out yesterday due to weakness.
Age: 87.0
Sex: F
Vaccine: VARZOS
Symptoms: Laboratory test, Mobility decreased, Muscle spasms, Nausea, Pain in extremity
Clinical narrative: Night of vaccination, I began to get in the middle of the night, feverish. Could not get out of bed. I had a severe headache, i was shivering, and my arm was killing me. I was so nauseous, couldn't take anything for my head. I could not get out of bed. Finally around 5-6 am, i managed to get out the bed. I had cramps and stomach pain. After that, I had achiness in my knees. Today is the first day that my arm is not sore. I didnt even want to go out yesterday due to weakness.
Age: 87.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Sleep disorder
Clinical narrative: Night of vaccination, I began to get in the middle of the night, feverish. Could not get out of bed. I had a severe headache, i was shivering, and my arm was killing me. I was so nauseous, couldn't take anything for my head. I could not get out of bed. Finally around 5-6 am, i managed to get out the bed. I had cramps and stomach pain. After that, I had achiness in my knees. Today is the first day that my arm is not sore. I didnt even want to go out yesterday due to weakness.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Atrial fibrillation, Blood creatinine increased, Blood lactic acid increased
Clinical narrative: COVID VAccine Breakthrough CAse  Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/15/21 (EN6207) COVID Positive 11/27/21  12/5/21: The patient is a 68-year-old male with a past medical history of CAD status post PCI, type 2 diabetes mellitus, hypertension, and hyperlipidemia presented to ED with complaints of shortness of breath.  He tested positive 8 days ago for COVID-19.  He was experiencing fatigue, body aches and chills prior to being tested.  He has been fully vaccinated against COVID-19 but has not received his booster.  His wife and daughter are currently positive for COVID-19 as well.  He did receive monoclonal antibody infusions 5 days ago on outpatient basis.  He continues to experience fever, body aches and worsening shortness of breath at rest and with activity.  He has had a normal appetite with no nausea, vomiting or diarrhea.  He reports normal oral intake.  No loss of taste or smell.   On arrival to ED the patient was febrile 101.2, tachycardic 128 and requiring 2 L of oxygen to maintain oxygen saturations of 95%.  Laboratory findings were significant for AKI BUN 37 and creatinine 1.41.  Lactic acidosis 2.4.  Leukocytosis 19.06.  D-dimer 1.06.  CT chest no PE marked enlargement of thyroid gland with left thyroid lobe calcification consistent with goiter.  Extensive patchy bilateral pneumonia consistent with atypical viral pneumonia.  Zithromax and ceftriaxone were initiated in ED. Patient received Decadron 10 mg IV.  IV fluid resuscitation was given with NS 0.9% 1 L bolus.  12/7/21: 68-year-old man who presented to the emergency department with worsening shortness of breath following diagnosis of COVID-19 infection 8 days prior status post monoclonal antibody infusion.  He was hypoxic requiring initiation of supplemental oxygen.  Twelve lead EKG revealed atrial fibrillation which is of apparent new onset.  He was admitted to the hospitalist Service, started on antiviral therapy with IV remdesivir, Decadron and empiric antibiotic therapy.  Eliquis was initiated for therapeutic anticoagulation, beta-blocker was continued for rate control.  Clinical response was favorable with progressive improvement in oxygen requirements.  Oxygen walk for home determination done on the day of discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea increased, COVID-19, Chills, Computerised tomogram thorax abnormal, Dyspnoea
Clinical narrative: COVID VAccine Breakthrough CAse  Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/15/21 (EN6207) COVID Positive 11/27/21  12/5/21: The patient is a 68-year-old male with a past medical history of CAD status post PCI, type 2 diabetes mellitus, hypertension, and hyperlipidemia presented to ED with complaints of shortness of breath.  He tested positive 8 days ago for COVID-19.  He was experiencing fatigue, body aches and chills prior to being tested.  He has been fully vaccinated against COVID-19 but has not received his booster.  His wife and daughter are currently positive for COVID-19 as well.  He did receive monoclonal antibody infusions 5 days ago on outpatient basis.  He continues to experience fever, body aches and worsening shortness of breath at rest and with activity.  He has had a normal appetite with no nausea, vomiting or diarrhea.  He reports normal oral intake.  No loss of taste or smell.   On arrival to ED the patient was febrile 101.2, tachycardic 128 and requiring 2 L of oxygen to maintain oxygen saturations of 95%.  Laboratory findings were significant for AKI BUN 37 and creatinine 1.41.  Lactic acidosis 2.4.  Leukocytosis 19.06.  D-dimer 1.06.  CT chest no PE marked enlargement of thyroid gland with left thyroid lobe calcification consistent with goiter.  Extensive patchy bilateral pneumonia consistent with atypical viral pneumonia.  Zithromax and ceftriaxone were initiated in ED. Patient received Decadron 10 mg IV.  IV fluid resuscitation was given with NS 0.9% 1 L bolus.  12/7/21: 68-year-old man who presented to the emergency department with worsening shortness of breath following diagnosis of COVID-19 infection 8 days prior status post monoclonal antibody infusion.  He was hypoxic requiring initiation of supplemental oxygen.  Twelve lead EKG revealed atrial fibrillation which is of apparent new onset.  He was admitted to the hospitalist Service, started on antiviral therapy with IV remdesivir, Decadron and empiric antibiotic therapy.  Eliquis was initiated for therapeutic anticoagulation, beta-blocker was continued for rate control.  Clinical response was favorable with progressive improvement in oxygen requirements.  Oxygen walk for home determination done on the day of discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea at rest, Dyspnoea exertional, Electrocardiogram abnormal, Fatigue, Fibrin D dimer
Clinical narrative: COVID VAccine Breakthrough CAse  Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/15/21 (EN6207) COVID Positive 11/27/21  12/5/21: The patient is a 68-year-old male with a past medical history of CAD status post PCI, type 2 diabetes mellitus, hypertension, and hyperlipidemia presented to ED with complaints of shortness of breath.  He tested positive 8 days ago for COVID-19.  He was experiencing fatigue, body aches and chills prior to being tested.  He has been fully vaccinated against COVID-19 but has not received his booster.  His wife and daughter are currently positive for COVID-19 as well.  He did receive monoclonal antibody infusions 5 days ago on outpatient basis.  He continues to experience fever, body aches and worsening shortness of breath at rest and with activity.  He has had a normal appetite with no nausea, vomiting or diarrhea.  He reports normal oral intake.  No loss of taste or smell.   On arrival to ED the patient was febrile 101.2, tachycardic 128 and requiring 2 L of oxygen to maintain oxygen saturations of 95%.  Laboratory findings were significant for AKI BUN 37 and creatinine 1.41.  Lactic acidosis 2.4.  Leukocytosis 19.06.  D-dimer 1.06.  CT chest no PE marked enlargement of thyroid gland with left thyroid lobe calcification consistent with goiter.  Extensive patchy bilateral pneumonia consistent with atypical viral pneumonia.  Zithromax and ceftriaxone were initiated in ED. Patient received Decadron 10 mg IV.  IV fluid resuscitation was given with NS 0.9% 1 L bolus.  12/7/21: 68-year-old man who presented to the emergency department with worsening shortness of breath following diagnosis of COVID-19 infection 8 days prior status post monoclonal antibody infusion.  He was hypoxic requiring initiation of supplemental oxygen.  Twelve lead EKG revealed atrial fibrillation which is of apparent new onset.  He was admitted to the hospitalist Service, started on antiviral therapy with IV remdesivir, Decadron and empiric antibiotic therapy.  Eliquis was initiated for therapeutic anticoagulation, beta-blocker was continued for rate control.  Clinical response was favorable with progressive improvement in oxygen requirements.  Oxygen walk for home determination done on the day of discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Goitre, Hypoxia, Laboratory test abnormal, Lactic acidosis, Leukocytosis
Clinical narrative: COVID VAccine Breakthrough CAse  Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/15/21 (EN6207) COVID Positive 11/27/21  12/5/21: The patient is a 68-year-old male with a past medical history of CAD status post PCI, type 2 diabetes mellitus, hypertension, and hyperlipidemia presented to ED with complaints of shortness of breath.  He tested positive 8 days ago for COVID-19.  He was experiencing fatigue, body aches and chills prior to being tested.  He has been fully vaccinated against COVID-19 but has not received his booster.  His wife and daughter are currently positive for COVID-19 as well.  He did receive monoclonal antibody infusions 5 days ago on outpatient basis.  He continues to experience fever, body aches and worsening shortness of breath at rest and with activity.  He has had a normal appetite with no nausea, vomiting or diarrhea.  He reports normal oral intake.  No loss of taste or smell.   On arrival to ED the patient was febrile 101.2, tachycardic 128 and requiring 2 L of oxygen to maintain oxygen saturations of 95%.  Laboratory findings were significant for AKI BUN 37 and creatinine 1.41.  Lactic acidosis 2.4.  Leukocytosis 19.06.  D-dimer 1.06.  CT chest no PE marked enlargement of thyroid gland with left thyroid lobe calcification consistent with goiter.  Extensive patchy bilateral pneumonia consistent with atypical viral pneumonia.  Zithromax and ceftriaxone were initiated in ED. Patient received Decadron 10 mg IV.  IV fluid resuscitation was given with NS 0.9% 1 L bolus.  12/7/21: 68-year-old man who presented to the emergency department with worsening shortness of breath following diagnosis of COVID-19 infection 8 days prior status post monoclonal antibody infusion.  He was hypoxic requiring initiation of supplemental oxygen.  Twelve lead EKG revealed atrial fibrillation which is of apparent new onset.  He was admitted to the hospitalist Service, started on antiviral therapy with IV remdesivir, Decadron and empiric antibiotic therapy.  Eliquis was initiated for therapeutic anticoagulation, beta-blocker was continued for rate control.  Clinical response was favorable with progressive improvement in oxygen requirements.  Oxygen walk for home determination done on the day of discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pneumonia, Pneumonia viral, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID VAccine Breakthrough CAse  Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/15/21 (EN6207) COVID Positive 11/27/21  12/5/21: The patient is a 68-year-old male with a past medical history of CAD status post PCI, type 2 diabetes mellitus, hypertension, and hyperlipidemia presented to ED with complaints of shortness of breath.  He tested positive 8 days ago for COVID-19.  He was experiencing fatigue, body aches and chills prior to being tested.  He has been fully vaccinated against COVID-19 but has not received his booster.  His wife and daughter are currently positive for COVID-19 as well.  He did receive monoclonal antibody infusions 5 days ago on outpatient basis.  He continues to experience fever, body aches and worsening shortness of breath at rest and with activity.  He has had a normal appetite with no nausea, vomiting or diarrhea.  He reports normal oral intake.  No loss of taste or smell.   On arrival to ED the patient was febrile 101.2, tachycardic 128 and requiring 2 L of oxygen to maintain oxygen saturations of 95%.  Laboratory findings were significant for AKI BUN 37 and creatinine 1.41.  Lactic acidosis 2.4.  Leukocytosis 19.06.  D-dimer 1.06.  CT chest no PE marked enlargement of thyroid gland with left thyroid lobe calcification consistent with goiter.  Extensive patchy bilateral pneumonia consistent with atypical viral pneumonia.  Zithromax and ceftriaxone were initiated in ED. Patient received Decadron 10 mg IV.  IV fluid resuscitation was given with NS 0.9% 1 L bolus.  12/7/21: 68-year-old man who presented to the emergency department with worsening shortness of breath following diagnosis of COVID-19 infection 8 days prior status post monoclonal antibody infusion.  He was hypoxic requiring initiation of supplemental oxygen.  Twelve lead EKG revealed atrial fibrillation which is of apparent new onset.  He was admitted to the hospitalist Service, started on antiviral therapy with IV remdesivir, Decadron and empiric antibiotic therapy.  Eliquis was initiated for therapeutic anticoagulation, beta-blocker was continued for rate control.  Clinical response was favorable with progressive improvement in oxygen requirements.  Oxygen walk for home determination done on the day of discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Thyroid calcification, Vaccine breakthrough infection, White blood cell count increased
Clinical narrative: COVID VAccine Breakthrough CAse  Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/15/21 (EN6207) COVID Positive 11/27/21  12/5/21: The patient is a 68-year-old male with a past medical history of CAD status post PCI, type 2 diabetes mellitus, hypertension, and hyperlipidemia presented to ED with complaints of shortness of breath.  He tested positive 8 days ago for COVID-19.  He was experiencing fatigue, body aches and chills prior to being tested.  He has been fully vaccinated against COVID-19 but has not received his booster.  His wife and daughter are currently positive for COVID-19 as well.  He did receive monoclonal antibody infusions 5 days ago on outpatient basis.  He continues to experience fever, body aches and worsening shortness of breath at rest and with activity.  He has had a normal appetite with no nausea, vomiting or diarrhea.  He reports normal oral intake.  No loss of taste or smell.   On arrival to ED the patient was febrile 101.2, tachycardic 128 and requiring 2 L of oxygen to maintain oxygen saturations of 95%.  Laboratory findings were significant for AKI BUN 37 and creatinine 1.41.  Lactic acidosis 2.4.  Leukocytosis 19.06.  D-dimer 1.06.  CT chest no PE marked enlargement of thyroid gland with left thyroid lobe calcification consistent with goiter.  Extensive patchy bilateral pneumonia consistent with atypical viral pneumonia.  Zithromax and ceftriaxone were initiated in ED. Patient received Decadron 10 mg IV.  IV fluid resuscitation was given with NS 0.9% 1 L bolus.  12/7/21: 68-year-old man who presented to the emergency department with worsening shortness of breath following diagnosis of COVID-19 infection 8 days prior status post monoclonal antibody infusion.  He was hypoxic requiring initiation of supplemental oxygen.  Twelve lead EKG revealed atrial fibrillation which is of apparent new onset.  He was admitted to the hospitalist Service, started on antiviral therapy with IV remdesivir, Decadron and empiric antibiotic therapy.  Eliquis was initiated for therapeutic anticoagulation, beta-blocker was continued for rate control.  Clinical response was favorable with progressive improvement in oxygen requirements.  Oxygen walk for home determination done on the day of discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Bite, Burning sensation, Nausea, Tremor, Vomiting
Clinical narrative: AT 3:00 AM PATIENT HAD NAUSEA AND VOMITING, SHAKING, AND BURNING. AT 4:30 PATIENT BEGAN BITING HIS LIPS VERY HARD.  FAMILY MEMBER CALLED 911 AND PATIENT WAS TRANSPORTED TO THE HOSPITAL.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hyperhidrosis, Muscular weakness
Clinical narrative: right arm weakness, bilateral lower extremity weakness x 4 days with multiple falls, sweats
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture positive, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cough
Clinical narrative: COVId Vaccine Breakthrough CAse  Moderna Dose 1 2/25/21 (024M20A) Moderna Dose 2 3/25/21 (036A21A) COVID Positive 12/4/21  12/5/21: Patient is a 73-year-old female vaccinated for COVID-19 presents to ER with chief complaint of generalized fatigue associated with intermittent fevers, cough, shortness of breath and diarrhea for the past 4 days, patient reports she tested positive for COVID-19 yesterday (12/4), noted to be hypoxic upon EMS assessment with oxygen saturation of 85% on room air patient was placed on 3 L of supplemental oxygen.  Evaluations completed the emergency room noted for leukocytosis of 14.61, chest x-ray suggested atypical viral pneumonia, patient was treated with IV Rocephin, supplemental oxygen, Tylenol for fever.  12/9/21: Patient was admitted for COVID-19 pneumonia with respiratory failure initially required supplemental oxygen. She was started on Decadron 6 mg daily along with remdesivir.  She was covered with empiric ceftriaxone and azithromycin for possible superimposed bacterial pneumonia. Did have 1 of 2 blood cultures positive for coag-negative staph and was given vancomycin for short time.  Patient had gradual improvement in oxygen requirements and on the day of discharge felt improved.  Home oxygen evaluation was performed which showed she needed room air at rest and 2 L of oxygen with exertion.  She will finish 5 further days of Decadron and be discharged with COVID-19 at home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Hypoxia, Leukocytosis
Clinical narrative: COVId Vaccine Breakthrough CAse  Moderna Dose 1 2/25/21 (024M20A) Moderna Dose 2 3/25/21 (036A21A) COVID Positive 12/4/21  12/5/21: Patient is a 73-year-old female vaccinated for COVID-19 presents to ER with chief complaint of generalized fatigue associated with intermittent fevers, cough, shortness of breath and diarrhea for the past 4 days, patient reports she tested positive for COVID-19 yesterday (12/4), noted to be hypoxic upon EMS assessment with oxygen saturation of 85% on room air patient was placed on 3 L of supplemental oxygen.  Evaluations completed the emergency room noted for leukocytosis of 14.61, chest x-ray suggested atypical viral pneumonia, patient was treated with IV Rocephin, supplemental oxygen, Tylenol for fever.  12/9/21: Patient was admitted for COVID-19 pneumonia with respiratory failure initially required supplemental oxygen. She was started on Decadron 6 mg daily along with remdesivir.  She was covered with empiric ceftriaxone and azithromycin for possible superimposed bacterial pneumonia. Did have 1 of 2 blood cultures positive for coag-negative staph and was given vancomycin for short time.  Patient had gradual improvement in oxygen requirements and on the day of discharge felt improved.  Home oxygen evaluation was performed which showed she needed room air at rest and 2 L of oxygen with exertion.  She will finish 5 further days of Decadron and be discharged with COVID-19 at home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia viral, Pyrexia, Respiratory failure, SARS-CoV-2 test positive, Staphylococcal infection
Clinical narrative: COVId Vaccine Breakthrough CAse  Moderna Dose 1 2/25/21 (024M20A) Moderna Dose 2 3/25/21 (036A21A) COVID Positive 12/4/21  12/5/21: Patient is a 73-year-old female vaccinated for COVID-19 presents to ER with chief complaint of generalized fatigue associated with intermittent fevers, cough, shortness of breath and diarrhea for the past 4 days, patient reports she tested positive for COVID-19 yesterday (12/4), noted to be hypoxic upon EMS assessment with oxygen saturation of 85% on room air patient was placed on 3 L of supplemental oxygen.  Evaluations completed the emergency room noted for leukocytosis of 14.61, chest x-ray suggested atypical viral pneumonia, patient was treated with IV Rocephin, supplemental oxygen, Tylenol for fever.  12/9/21: Patient was admitted for COVID-19 pneumonia with respiratory failure initially required supplemental oxygen. She was started on Decadron 6 mg daily along with remdesivir.  She was covered with empiric ceftriaxone and azithromycin for possible superimposed bacterial pneumonia. Did have 1 of 2 blood cultures positive for coag-negative staph and was given vancomycin for short time.  Patient had gradual improvement in oxygen requirements and on the day of discharge felt improved.  Home oxygen evaluation was performed which showed she needed room air at rest and 2 L of oxygen with exertion.  She will finish 5 further days of Decadron and be discharged with COVID-19 at home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection, White blood cell count increased
Clinical narrative: COVId Vaccine Breakthrough CAse  Moderna Dose 1 2/25/21 (024M20A) Moderna Dose 2 3/25/21 (036A21A) COVID Positive 12/4/21  12/5/21: Patient is a 73-year-old female vaccinated for COVID-19 presents to ER with chief complaint of generalized fatigue associated with intermittent fevers, cough, shortness of breath and diarrhea for the past 4 days, patient reports she tested positive for COVID-19 yesterday (12/4), noted to be hypoxic upon EMS assessment with oxygen saturation of 85% on room air patient was placed on 3 L of supplemental oxygen.  Evaluations completed the emergency room noted for leukocytosis of 14.61, chest x-ray suggested atypical viral pneumonia, patient was treated with IV Rocephin, supplemental oxygen, Tylenol for fever.  12/9/21: Patient was admitted for COVID-19 pneumonia with respiratory failure initially required supplemental oxygen. She was started on Decadron 6 mg daily along with remdesivir.  She was covered with empiric ceftriaxone and azithromycin for possible superimposed bacterial pneumonia. Did have 1 of 2 blood cultures positive for coag-negative staph and was given vancomycin for short time.  Patient had gradual improvement in oxygen requirements and on the day of discharge felt improved.  Home oxygen evaluation was performed which showed she needed room air at rest and 2 L of oxygen with exertion.  She will finish 5 further days of Decadron and be discharged with COVID-19 at home program.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: Ringing in both ears. Its started after my 1st vaccination in April 2021, its grew louder after my 2nd vaccination in March 2021. I was referred to an audiologist by my Doctor. I was basically told that it might disappear as suddenly a it appeared and to keep updating my Doctor. I was able to ignore it for the most part although it became bothersome in the evening.  There was no noticeable change after my 3rd vaccination in October 2021, however it got "louder" after the 4th in April 2022. I have advised my Doctor of this and we are discussing the possibility of a 2bd referral.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hypoxia, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: COVID 19 that lead to hospitalization. Patient was hospitalized for 1 full day. Presented with fever, mildy hypoxic, lower extremity selling and pain.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest X-ray normal, Injected limb mobility decreased, Injection site pain, Laboratory test
Clinical narrative: She got her vaccine, she just thought she had a normal reaction to the vaccine.  She started putting alcohol on it and subsided some.  Then noticed as she was using the arm, it was still tender, hard to move a little and brushed it off.  She is still having this issue, going into her shoulder blade and annoying to her.  She has put Ben-Gay on it and nothing seems to alleviate the symptoms and does not do anything to aggravate it.  She looked in the mirror as it was given on the back of her arm, can feel it but can't see it.  She then had it checked out, went to the ER because her shoulder blade was hurting, one of her friends suggested it might be her heart.  She went and had that checked out, had x-rays done and that was cleared.  She had never had this sensation on the left side of her body until she got the shot.  If she puts her elbow down on her chair she knows there is an issue, constant reminder of this.  She now has to put a heating pad on it.  She doesn't do any type of work to aggravate it and doesn't lift anything.  She cannot shake it off and is reporting it as it does not seem to go away.  Her previous doctor Dr. just brushed her off regarding her symptoms.   The pain goes from her shoulder blade area between the neck and the end of her scapula hurts.  It's a dull pain, knows it's there but if she presses on it then that's when she has the after effect.  She has been treating this herself at this point and is not improving.  The injection site is still  tender, nagging type feeling that did travel to her shoulder blade.    She did see on TV where they squeezed the muscle and give the injection feels she did not get it in that muscle, got it below that on the back side of her arm.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal pain, Neck pain, Pain, Tenderness
Clinical narrative: She got her vaccine, she just thought she had a normal reaction to the vaccine.  She started putting alcohol on it and subsided some.  Then noticed as she was using the arm, it was still tender, hard to move a little and brushed it off.  She is still having this issue, going into her shoulder blade and annoying to her.  She has put Ben-Gay on it and nothing seems to alleviate the symptoms and does not do anything to aggravate it.  She looked in the mirror as it was given on the back of her arm, can feel it but can't see it.  She then had it checked out, went to the ER because her shoulder blade was hurting, one of her friends suggested it might be her heart.  She went and had that checked out, had x-rays done and that was cleared.  She had never had this sensation on the left side of her body until she got the shot.  If she puts her elbow down on her chair she knows there is an issue, constant reminder of this.  She now has to put a heating pad on it.  She doesn't do any type of work to aggravate it and doesn't lift anything.  She cannot shake it off and is reporting it as it does not seem to go away.  Her previous doctor Dr. just brushed her off regarding her symptoms.   The pain goes from her shoulder blade area between the neck and the end of her scapula hurts.  It's a dull pain, knows it's there but if she presses on it then that's when she has the after effect.  She has been treating this herself at this point and is not improving.  The injection site is still  tender, nagging type feeling that did travel to her shoulder blade.    She did see on TV where they squeezed the muscle and give the injection feels she did not get it in that muscle, got it below that on the back side of her arm.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No reactions occurred. Vaccine administered on 4-13-22, however due to it being kept in fridge it should have expired on 4-8-22, therefore pt received expired vaccine.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 2/6/21 (lot NA) Pfizer Dose 2 3/6/21 (lot NA) COVID Positive 11/27/2021  12/5/21: 66-year-old man who was brought into the emergency department with worsening shortness of breath, hypoxia following COVID diagnosis 9 days ago.  He reports feeling unwell approximately 2 weeks ago with generalized myalgias, low-grade fevers, shortness of breath.  He subsequently had COVID-19 PCR testing 10 days ago which was positive.  He has had COVID vaccines x2, scheduled for booster dose prior to onset of illness.  His status post monoclonal antibody infusion as outpatient despite which he has had worsening symptoms.  He has noted desaturation particularly with activity with oxygen saturation down to 88-89% on room air.   he continues to have low-grade fevers, poor appetite with poor oral intake, shortness of breath aggravated by exertion.  Presented to the emergency department where he was hypoxic on room air to 88%, laboratories  Revealed lactic acidosis, elevated D-dimer.  He has a contrast dye allergy precluding stat CT pulmonary angiogram, ventilation perfusion scan pending.  He will be admitted to the hospitalist service for further treatment and evaluation.  12/7/21: 66-year-old man who presented worsening shortness of breath, cough and myalgias following COVID-19 infection diagnosis 9 days ago.  On evaluation in the emergency department he was found to be hypoxic down to 88% on room air.  Chest x-ray demonstrated bilateral infiltrates in keeping with viral pneumonitis, elevated D-dimer was noted however ventilation perfusion scan done on account of contrast dye allergy was low probability for pulmonary embolism.  He was admitted to the hospitalist service and started on IV remdesivir, Decadron, empiric antibiotic therapy with good effect.  Significant improvement in oxygen requirements were noted during hospital course.  Oxygen walk for home determination done prior to discharge revealed that he did not meet criteria for home oxygen.  Has been discharged in stable medical condition to continue outpatient follow-up.